Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine besylate + benazepril hydrochloride tablets for essential hypertension
ChiCTR1900025826Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amlodipine and benazepril in essential hypertension, sponsored by Qilu Hospital of Shandong University. Primary endpoints: 24-hour ambulatory blood pressure and Left atrial diameter. Started Sep 2019; status: recruiting.
02
Drugs
amlodipinebenazepril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR1900025826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025826.